Zhai, Y.; Zheng, X.; Mao, Y.; Li, K.; Liu, Y.; Gao, Y.; Zhao, M.; Yang, R.; Yu, R.; Chen, W.
Recombinant Human Thymosin β4 (rhTβ4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease. Int. J. Mol. Sci. 2022, 23, 5458.
https://doi.org/10.3390/ijms23105458
AMA Style
Zhai Y, Zheng X, Mao Y, Li K, Liu Y, Gao Y, Zhao M, Yang R, Yu R, Chen W.
Recombinant Human Thymosin β4 (rhTβ4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease. International Journal of Molecular Sciences. 2022; 23(10):5458.
https://doi.org/10.3390/ijms23105458
Chicago/Turabian Style
Zhai, Yanfang, Xiaoxiang Zheng, Yunyun Mao, Kai Li, Yanhong Liu, Yuemei Gao, Mengsu Zhao, Rui Yang, Rui Yu, and Wei Chen.
2022. "Recombinant Human Thymosin β4 (rhTβ4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease" International Journal of Molecular Sciences 23, no. 10: 5458.
https://doi.org/10.3390/ijms23105458
APA Style
Zhai, Y., Zheng, X., Mao, Y., Li, K., Liu, Y., Gao, Y., Zhao, M., Yang, R., Yu, R., & Chen, W.
(2022). Recombinant Human Thymosin β4 (rhTβ4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease. International Journal of Molecular Sciences, 23(10), 5458.
https://doi.org/10.3390/ijms23105458
